Overview

Behavior and Naltrexone Treatment for Alcoholics

Status:
Completed
Trial end date:
2000-03-01
Target enrollment:
Participant gender:
Summary
The study's purpose is to improve alcoholism treatment by investigating the combined effectiveness of a psychotherapy (Coping Skills Training and Cue Exposure Treatment - CSTCET) with naltrexone in a randomized clinical trial. Individuals will receive 2 weeks of CSTCET or a control treatment as inpatients followed by 12 consecutive weeks of receiving either naltrexone or placebo as outpatients. Followups at 24, 48, and 72 weeks after treatment is completed.
Phase:
Phase 4
Details
Lead Sponsor:
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Treatments:
Naltrexone